Ensure you rotate the injection site every week to avoid skin irritation or other kinds of reactions on the area
Popular diabetes and weight-loss drugs, including Ozempic (NVO) and Zepbound (LLY), may have a potential link with several eye conditions that can cause vision loss, according to a new investigatory review published recently in the scientific journal JAMA Ophthalmology
GLP-1 receptor activation complements this by promoting mitochondrial turnover, the process by which damaged or dysfunctional mitochondria are cleared and replaced, and by reducing the production of reactive oxygen species, the unstable molecules that accumulate during metabolic stress and accelerate cellular damage
For more information on safety and usage, visit the Ozempic safety page or the Metformin safety page
Hygum K, Harslf T, Jrgensen NR, Rungby J, Pedersen SB, Langdahl BL